Ingevity Corp buy BMO Capital Markets
Start price
07.08.25
/
50%
€40.88
Target price
07.08.26
€53.17
Performance (%)
47.14%
Price
23.02.26
€60.20
Summary
This prediction is currently active. With a performance of 47.14% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 07.08.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -6.011% | -6.011% |
| iShares Core DAX® | 0.608% | 0.340% |
| iShares Nasdaq 100 | 0.636% | -3.172% |
| iShares Nikkei 225® | -0.128% | 8.916% |
| iShares S&P 500 | 0.544% | -0.699% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat